BIOMAT Database Logo BIOMAT Database Logo

Does perforin mediate the direct injury of renal allograft in acute rejection? 1993

T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
First Department of Surgery, Okayama University Medical School, Japan.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
The role of chemokines in acute renal allograft rejection and chronic allograft injury.
January 2009, Frontiers in bioscience (Landmark edition),
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
January 2003, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Does ischemic injury augment allograft rejection?
April 1990, Transplantation proceedings,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Acute humoral renal allograft rejection.
March 2002, Current opinion in urology,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Eosinophils in acute renal allograft rejection.
January 1994, Transplant immunology,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Accelerated acute rejection in renal allograft.
June 1996, Transplantation proceedings,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Ischemia, injury, and renal allograft rejection.
March 1996, Current opinion in nephrology and hypertension,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Acute allograft pancreatitis associated with renal allograft rejection.
February 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Acute rejection and renal allograft outcome.
January 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Matsuno, and K Sakagami, and S Saito, and Y Naomoto, and K Okumura, and K Orita
Renal epithelial cells retain primary cilia during human acute renal allograft rejection injury.
November 2019, BMC research notes,
Copied contents to your clipboard!